drugset / Trial / NCT00420563
Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
The scope of the trial is to assess the free progression rate at 2 months for each group of patients.
Timeline
- Start
- 2009-09-25
- Primary completion
- 2011-01-19
- Completion
- 2011-01-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | 50 mg | Oral |
| Comparator | Megestrol Acetate | Other / unclassified | 320 mg | Oral |